Clinical implication and prognostic significance of standardised uptake value of primary non-small cell lung cancer on positron emission tomography: analysis of 176 cases

Affiliations


Abstract

Objective: We sought to assess the clinical implication and prognostic significance of maximum standardised uptake value (SUV(max)) of primary non-small cell lung cancer (NSCLC) staged by integrated PET-CT.

Methods: A retrospective review was carried out on 176 consecutive patients with histologically proven NSCLC who underwent staging with integrated PET-CT prior to curative intent surgical resection. SUV(max) of primary NSCLC were measured and correlated with tumour characteristics, lymph node involvement, surgical stage, type of surgical resection and survival following resection.

Results: SUV(max) was significantly higher in centrally located tumours, tumours > or =4.0 cm, squamous cell subtype, poorly differentiated tumours, advanced T stage, advanced nodal stage, pleural invasion, and patients requiring complex surgical resection. SUV(max) value of 15 was the best discriminative cut-off value for survival generated by log-rank test. When patients were stratified based on this value, those with SUV(max) >15 were more likely to have centrally located tumours, squamous cell subtype, advanced T stage, advanced nodal stage, advanced American Joint Committee on Cancer (AJCC) stage, larger tumour size and required more advanced surgical resections than a simple lobectomy. Overall survival was significantly longer for patients with SUV(max) < or =15 than those with SUV(max) >15. Furthermore, nodal stage specific survival following resection (i.e. non-N2 and N2) were significantly better in patients with SUV(max) < or =15 than SUV(max) >15.

Conclusion: SUV(max) correlates with tumour characteristics, surgical stage and prognosis following resection. SUV(max) may be a useful preoperative tool, in addition to other known prognostic markers, in allocating patients with potentially poor prognosis preoperatively to neoadjuvant chemotherapy prior to resection in order to improve their overall survival. Prospective and randomised trials are warranted.


Similar articles

Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.

Al-Sarraf N, Aziz R, Gately K, Lucey J, Wilson L, McGovern E, Young V.Eur J Cardiothorac Surg. 2008 Jan;33(1):104-9. doi: 10.1016/j.ejcts.2007.09.026. Epub 2007 Oct 30.PMID: 17977738

Risk factors for predicting the occult nodal metastasis in T1-2N0M0 NSCLC patients staged by PET/CT: potential value in the clinic.

Li L, Ren S, Zhang Y, Guan Y, Zhao J, Liu J, Wang Q, Chen G, Chen H, Xiang J, Fu X.Lung Cancer. 2013 Aug;81(2):213-7. doi: 10.1016/j.lungcan.2013.04.012. Epub 2013 May 9.PMID: 23664030

Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.

Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S, Rusch V.J Clin Oncol. 2004 Aug 15;22(16):3255-60. doi: 10.1200/JCO.2004.11.109.PMID: 15310769

Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.

Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22.PMID: 19464906 Review.

Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project.

Berghmans T, Dusart M, Paesmans M, Hossein-Foucher C, Buvat I, Castaigne C, Scherpereel A, Mascaux C, Moreau M, Roelandts M, Alard S, Meert AP, Patz EF Jr, Lafitte JJ, Sculier JP; European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project.J Thorac Oncol. 2008 Jan;3(1):6-12. doi: 10.1097/JTO.0b013e31815e6d6b.PMID: 18166834 Review.


Cited by

Role of Radiomics Features and Machine Learning for the Histological Classification of Stage I and Stage II NSCLC at [18F]FDG PET/CT: A Comparison between Two PET/CT Scanners.

Dondi F, Gatta R, Albano D, Bellini P, Camoni L, Treglia G, Bertagna F.J Clin Med. 2022 Dec 29;12(1):255. doi: 10.3390/jcm12010255.PMID: 36615053 Free PMC article.

Prognostic Value of Positron Emission Tomography in Advanced Cholangiocarcinoma: A Single-Institution Study and Literature Review.

Pevner JL, Tanvetyanon T.Cureus. 2022 Nov 2;14(11):e31026. doi: 10.7759/cureus.31026. eCollection 2022 Nov.PMID: 36475189 Free PMC article.

Invasive area to tumor ratio is a significant prognostic factor for non-small cell lung cancer.

Motono N, Mizoguchi T, Ishikawa M, Iwai S, Iijima Y, Uramoto H.Thorac Cancer. 2022 Nov;13(21):2935-2940. doi: 10.1111/1759-7714.14616. Epub 2022 Sep 30.PMID: 36177984 Free PMC article.

Relationships between SUVmax of lung adenocarcinoma and different T stages, histological grades and pathological subtypes: a retrospective cohort study in China.

Sun X, Chen T, Xie C, Liu L, Lei B, Wang L, Ruan M, Yan H, Zhang Q, Chang C, Xie W.BMJ Open. 2022 May 17;12(5):e056804. doi: 10.1136/bmjopen-2021-056804.PMID: 35580966 Free PMC article.

Prognostic Value of MTV and TLG of 18F-FDG PET in Patients with Stage I and II Non-Small-Cell Lung Cancer: a Meta-Analysis.

Wen W, Piao Y, Xu D, Li X.Contrast Media Mol Imaging. 2021 Nov 22;2021:7528971. doi: 10.1155/2021/7528971. eCollection 2021.PMID: 34887713 Free PMC article. Review.


KMEL References